Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market, Global Outlook and Forecast 2025-2032
According to a recent report from Stats Market Research, the global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market was valued at approximately USD 3,505 million in 2023 and is projected to reach USD 5,032.05 million by 2032, reflecting a steady Compound Annual Growth Rate (CAGR) of 4.10% during the forecast period. This growth trajectory […]
